Expert Blog | Beta Cells in Diabetes

Expert BlogBlog RSS

About the Blog

This forum allows a wide variety of leading researchers, endocrinologists, and primary care providers to expand informally on emerging research, case studies, and resources related to beta cells in diabetes, as well providing an opportunity for you to discuss and debate these issues.

Posts by Topic

Beta cell pathophysiology 14
DPP-4 inhibitors 7
GLP-1 agonists 12
Glycemic control 19
Insulin therapy 11
Lifestyle changes 8
Metformin 7
Prediabetes 5
Sulfonylureas (SUs) 5
Thiazolidinediones (TZDs) 12
Weight 5

Posts by Author

Aaron Kowalski, PhD 1
Carol Wysham, MD 1
Christopher J. Rhodes, PhD 2
Doron Schneider, MD, FACP 6
Eugene Wright, Jr., MD 2
Irl B. Hirsch, MD 6
Jennifer Larsen, MD 1
John L. Leahy, MD 4
Kevin A. Peterson, MD, MPH 6
Kim C. Dixon, MD 1
Patricia Brubaker, PhD 1
Robert H. Eckel, MD 1
Sonal Singh, MD, MPH 2

Carol Wysham, MD
Endocrinologist

Research Professor, Department of Pharmacotherapy, Washington State University
Assistant Clinical Professor of Medicine, University of Washington School of Medicine
Staff Endocrinologist, Department of Endocrinology, Rockwood Clinic

Read the full biography

When Does Tight Glycemic Control Affect CVD Risk?
Posted March 25, 2011 by Carol Wysham, MD

Tags: glycemic control

It is abundantly clear that cardiovascular disease is a major driver of the morbidity, mortality, and health care costs associated with type 2 diabetes mellitus (T2DM).
- Continue Reading
- 1 Comment

Betacell

A resource for physicians established by the Endocrine Society

Text Size:

Expert BlogBlog RSS

About the Blog

Posts by Topic

Posts by Author

When Does Tight Glycemic Control Affect CVD Risk?